|
FY2025
12 months to Sep 27, 2025
|
FY2024
12 months to Sep 28, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Oct 1, 2022
|
FY2021
12 months to Oct 2, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Selling, general and administrative | |||||
| Research and development | |||||
| Acquisition and integration charges | |||||
| Restructuring | |||||
| Total operating expenses | |||||
| Operating income | |||||
| Interest income | |||||
| Interest expense | |||||
| Other income (expense), net | |||||
| Interest and other, net | |||||
| Income before income taxes | |||||
| Provision for income taxes | |||||
| Net income before noncontrolling interest | |||||
| Less: Net income attributable to noncontrolling interest | |||||
| Net income attributable to common shareholders | |||||
| Net income attributable to common shareholders per share: | |||||
| Basic | |||||
| Diluted | |||||
| Weighted-average shares used in computing per share amounts: | |||||
| Basic | |||||
| Diluted | |||||
Loading...